Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safetyFlecainide: Current status and perspectives in arrhythmia managementRecent developments in atrial fibrillation.The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm.Optimal management with Class I and Class III antiarrhythmic drugs should be done in the outpatient setting: protagonist.Antiarrhythmic drugs for atrial fibrillation.Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy.Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Progress in nonpharmacologic therapy of atrial fibrillation.Rate versus rhythm control in the management of patients with atrial fibrillation.Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.Role of Bi-Atrial Pacing In Slowing The Progression of Paroxysmal Atrial Fibrillation To Permanent Atrial Fibrillation.Safety of flecainide.Flecainide acetate for the treatment of atrial and ventricular arrhythmias.Novel ion channel targets in atrial fibrillation.Antiarrhythmic drug therapy in the management of atrial fibrillation.Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.Rhythm management in atrial fibrillation--with a primary emphasis on pharmacologic therapy: Part 3.Atrial fibrillation
P2860
Q24187110-0ED4A8F0-F5B0-4A79-93BE-A768C7D8C370Q24197643-DC790353-86B9-4397-880E-A450BF50E2CAQ24243067-F1390AFA-E107-4885-9E04-1761A8F21047Q26852003-B93D8C05-D1DB-4C0B-948A-55F96E14FCA7Q28081935-68E1CE6C-118E-4FDC-BAB2-4E5F5CD394D7Q30854979-F8AEB1EB-6FB5-48BB-BC21-6A3242301882Q33160108-8209FDF5-3F7F-4FCF-89A2-5701F99A97D5Q33597990-ADA7574F-55C9-40FF-91E9-6607936C72DFQ33598017-B16DC72C-4B92-4DE3-AF03-2D5DC2B23229Q33821199-E3ED8F23-D7B2-436E-9410-7A262E1FD5BEQ34989738-D79C64BA-C3F4-462E-BD2F-E818D9506C39Q35547234-E5734AF2-374F-414B-83C4-1C5037AB96A3Q35684059-3A0A1E6A-E6C3-41FC-8C65-4114F33A9440Q36269171-15F81C9B-E014-49EC-8A5B-3DD1B230BE5AQ37495932-D0982F6D-A6AA-4AAB-93E7-9867234972ABQ37496020-35E35091-6104-4CF2-B0B7-2D7E38D87244Q37995638-866EEA32-DEBB-441A-9DF5-EF180C44287CQ38072091-4D91F90D-F423-4C0D-9657-0CFBCFDCE431Q38751315-6C36AFD7-EFF1-4E08-A229-1149FF8121CAQ41639389-F84BC8D1-B335-4613-B249-7EFC099A7064Q42285626-B57F4548-DAC6-4204-906E-1CB327BBB4E3Q46533628-87994276-F4EF-444E-A284-D2CCF3D287FFQ47628139-03CB3C71-0E1B-4A1C-93D4-24594C7ACD99Q52242767-ADA1F76D-0368-41C9-9C3B-7D6190870BE2Q56607936-00BC901D-49FA-4B88-A07C-A76FA15A59CB
P2860
Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Prospective comparison of flec ...... rial Fibrillation Study Group.
@en
Prospective comparison of flec ...... rial Fibrillation Study Group.
@nl
type
label
Prospective comparison of flec ...... rial Fibrillation Study Group.
@en
Prospective comparison of flec ...... rial Fibrillation Study Group.
@nl
prefLabel
Prospective comparison of flec ...... rial Fibrillation Study Group.
@en
Prospective comparison of flec ...... rial Fibrillation Study Group.
@nl
P2093
P1476
Prospective comparison of flec ...... rial Fibrillation Study Group.
@en
P2093
Hohnloser SH
Naccarelli GV
P304
P356
10.1016/S0002-9149(97)89118-7
P407
P577
1996-01-01T00:00:00Z